Axsome Therapeutics, Inc. (AXSM)
198.52
-0.50
(-0.25%)
USD |
NASDAQ |
Aug 31, 16:00
198.62
+0.10
(+0.05%)
After-Hours: 05:18
Axsome Therapeutics Total Long Term Debt (Quarterly) : 154.05M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 154.05M |
| March 31, 2026 | 149.27M |
| December 31, 2025 | 147.68M |
| September 30, 2025 | 147.86M |
| June 30, 2025 | 146.97M |
| March 31, 2025 | 210.78M |
| December 31, 2024 | 191.12M |
| September 30, 2024 | 190.67M |
| June 30, 2024 | 190.38M |
| March 31, 2024 | 188.28M |
| December 31, 2023 | 185.10M |
| September 30, 2023 | 185.14M |
| June 30, 2023 | 184.36M |
| March 31, 2023 | 147.62M |
| December 31, 2022 | 94.26M |
| September 30, 2022 | 93.91M |
| June 30, 2022 | 93.46M |
| March 31, 2022 | 49.31M |
| December 31, 2021 | 49.09M |
| September 30, 2021 | 49.17M |
| June 30, 2021 | 48.96M |
| March 31, 2021 | 48.93M |
| Date | Value |
|---|---|
| December 31, 2020 | 48.90M |
| September 30, 2020 | 48.03M |
| June 30, 2020 | 20.29M |
| March 31, 2020 | 20.11M |
| December 31, 2019 | 19.93M |
| September 30, 2019 | 19.76M |
| June 30, 2019 | 19.58M |
| March 31, 2019 | 19.35M |
| December 31, 2018 | 6.911M |
| September 30, 2018 | 7.726M |
| June 30, 2018 | 8.471M |
| March 31, 2018 | 9.208M |
| December 31, 2017 | 9.932M |
| September 30, 2017 | 10.09M |
| June 30, 2017 | 9.973M |
| March 31, 2017 | 8.775M |
| December 31, 2016 | 9.470M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Eli Lilly & Co. | 49.62B |
| Liquidia Corp. | 182.90M |
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 145.15M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |